Please login to the form below

A Pharma Marketer's Guide to the Mobile Web

Despite an acknowledgement of the importance of mobile by the pharma sector, there has been little evidence to show that businesses are harnessing the mobile web effectively, instead opting for mobile app development. This guide sheds some light on mobile web opportunities for Pharma.
Find out what you could be doing to develop your mobile presence effectively, by downloading A Pharma Marketer's Guide to the Mobile Web, which was first published in November 2012.

High-level findings include:

 - Patients’ needs for content are poorly served: only two European sites (both
   concerned with contraception, from HRA and MSD UK) seem to recognise and
   address patient audiences, though they serve these needs to widely differing

 - Responsive design techniques for developing cross-device content are
 Astellas stands out strongly for its European corporate level

 - Users with feature-phones are largely ignored: only (providing
   investor information) offers a mobile resource fully accessible and usable through
   these devices.

 - Mobile is (too often) an island: 
typically, mobile optimisation is reserved for a
   single site in a company’s brand portfolio (the global, and when a
   browsing journey leads to other properties (e.g. careers, investor or product – let
   alone patient – info) the user is passed to a desktop site. It’s also an island where
   the natives only speak English.

 - Attention to detail is low across all sites: while homepages tend to look
   attractive, our review highlights examples both of failure to implement W3C mobile
   best practices (such as making all numbers click to call and providing links back
   to a full site) and of flawed user acceptance testing which hasn’t detected broken
   or missing links.

9th April 2013



Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Blue Latitude Health
Crusader House
145-157 St John Street
United Kingdom

Latest content on this profile

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big data.
Blue Latitude Health
Lynch syndrome: a patient perspective
Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options, and gives his advice for healthcare professionals diagnosing patients with a genetic disease.
Blue Latitude Health
What does programmatic advertising mean for your pharma marketing strategy?
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.
Blue Latitude Health
How to measure marketing success: profit vs ROI
Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.
Blue Latitude Health
Perspective on biotech leaders
In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.
Blue Latitude Health
Global customer research in healthcare: 10 tips for capturing insights that matter
What makes a strong brand? One global core coupled with sensitivity to regions and countries. In part two of our series on customer insight and behaviour change, we share our tips on optimising global customer research projects to ensure you get the balance right in an efficient way.
Blue Latitude Health